Here are three findings from the report:
• The general intravenous anesthesia drugs market is dominating the U.S. anesthesia drugs market.
• Propofol and Benzodiazepines Class (Diazepam and Midazolam) are the top contributors to intravenous anesthetic drugs.
• Baxter International, Endo Health Solutions, AstraZeneca and Abbott Laboratories are four main players, but other companies also play a major role in the market.
More articles on anesthesia:
NAPA Dr. Joseph Marino to study treatment for postoperative pain relief
ASA President Dr. J.P. Abenstein on the physician-led ASC anesthesia team
Dr. Eugene Pereira joins Sarasota Memorial Health Care System
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
